
Transhumanism and genetics, or how to create bespoke babies
Whilst there is an international consensus against the deliberate genetic modification of the human species following the birth of the “CRISPR babies” in China in 2018, biotechnology companies in Silicon Valley, backed by a group of billionaire investors, are working to create genetically modified or hand-picked babies. This phenomenon, which is no longer the stuff of science fiction, is accompanied by attempts to normalise such modifications to the human species.

In China, a death following safety failures in a gene therapy trial
In late July 2026, an article published in the journal Science revealed, more than a year after the event took place, the death of a six-year-old girl following a gene therapy trial in China. This therapy was based on new techniques of genetic modification (so-called new genomic techniques – NGT) and used viral vectors to deliver the gene modifying material to the target cells.

